Delivery Order SPE2DB22D3501-SPE2DB25FXM08
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets (5 units) on August 22, 2025, with completion targeted for September 15, 2025. This non-set-aside award represents a child order under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $10,238.74 delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $5,119.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for INQOVI 35 mg-100 mg tablets (5-count units), with performance expected in Conshohocken, Pennsylvania by September 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INQOVI 35 MG-100 MG tablets. The $4,830.47 contract has a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,119.36 to AmerisourceBergen Drug Corp for the supply of INQOVI 35 MG-100 MG tablets in quantities of 5 units. This firm fixed price, non-set-aside contract was awarded on September 24, 2025, with an ultimate completion date of October 16, 2025. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- This delivery order, issued by the Defense Logistics Agency (DLA) on July 23, 2025, awards AmerisourceBergen Drug Corp $5,119.36 for the supply of INQOVI 35 mg-100 mg tablets in quantities of 5 units. The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with a completion date of August 13, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $10,238.74 to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets on September 12, 2025, with a completion date of October 3, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. INQOVI is a prescribed oncology medication used in the treatment of certain myelodysplastic syndromes and acute myeloid...
- This is a $5,119.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of INQOVI 35 MG-100 MG tablets in unit dose packages of five. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,119.36 and an ultimate completion date of May 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INQOVI is a prescription...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $9,660.94, is for the delivery of the specialty medication INQOVI 35 MG-100 MG TABLET with a completion date of March 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as...